Han J, Leppik L, Sztulman L, de Rosa R, Pfeiffer V, Busse L
Cells. 2025; 14(4).
PMID: 39996771
PMC: 11854772.
DOI: 10.3390/cells14040300.
Chen Z, Yang Y, Huang X, Cheng Y, Qu Y, Heng Q
Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(1):43-51.
PMID: 39819711
PMC: 11744294.
DOI: 10.12122/j.issn.1673-4254.2025.01.06.
Han G, Hu K, Luo T, Wang W, Zhang D, Ouyang L
Apoptosis. 2025; .
PMID: 39755822
DOI: 10.1007/s10495-024-02066-w.
Zhang H, Zhou Y, Jiang C, Jian N, Wang J
Int J Biol Sci. 2024; 20(10):3802-3822.
PMID: 39113708
PMC: 11302871.
DOI: 10.7150/ijbs.93644.
Ferrone M, Ciccarelli M, Varzideh F, Kansakar U, Guerra G, Cerasuolo F
Cardiovasc Diabetol. 2024; 23(1):268.
PMID: 39039512
PMC: 11265336.
DOI: 10.1186/s12933-024-02331-x.
CircNSD1 promotes cardiac fibrosis through targeting the miR-429-3p/SULF1/Wnt/β-catenin signaling pathway.
Ji D, Jin S, Jiang Y, Xu F, Fan S, Zhao Y
Acta Pharmacol Sin. 2024; 45(10):2092-2106.
PMID: 38760544
PMC: 11420342.
DOI: 10.1038/s41401-024-01296-7.
The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms.
Kesidou D, Beqqali A, Baker A
Cardiovasc Res. 2024; 120(3):217-219.
PMID: 38484215
PMC: 10939457.
DOI: 10.1093/cvr/cvae033.
Exosomal circSCMH1/miR-874 ratio in serum to predict carotid and coronary plaque stability.
Wang J, Liu Y, Tian P, Xing L, Huang X, Fu C
Front Cardiovasc Med. 2023; 10:1277427.
PMID: 38149265
PMC: 10750349.
DOI: 10.3389/fcvm.2023.1277427.
Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study.
Valdiviesso R, Amaral T, Moreira E, Sousa-Santos A, Fernandes M, Aguiar M
BMC Cardiovasc Disord. 2023; 23(1):594.
PMID: 38053018
PMC: 10696669.
DOI: 10.1186/s12872-023-03632-x.
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome.
Katsioupa M, Kourampi I, Oikonomou E, Tsigkou V, Theofilis P, Charalambous G
Life (Basel). 2023; 13(10).
PMID: 37895374
PMC: 10608753.
DOI: 10.3390/life13101992.
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach.
Salvatori F, DAversa E, Serino M, Singh A, Secchiero P, Zauli G
Int J Mol Sci. 2023; 24(17).
PMID: 37686073
PMC: 10487654.
DOI: 10.3390/ijms241713268.
Propofol synergizes with circAPBB2 to protect against hypoxia/reoxygenation-induced oxidative stress, inflammation, and apoptosis of human cardiomyocytes.
Jin C, Yuan S, Piao L, Ren M, Liu Q
Immun Inflamm Dis. 2023; 11(8):e952.
PMID: 37647434
PMC: 10408373.
DOI: 10.1002/iid3.952.
Cardiomyocyte Ploidy, Metabolic Reprogramming and Heart Repair.
Elia A, Mohsin S, Khan M
Cells. 2023; 12(12).
PMID: 37371041
PMC: 10296973.
DOI: 10.3390/cells12121571.
Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease.
Gambardella J, Fiordelisi A, Cerasuolo F, Buonaiuto A, Avvisato R, Viti A
iScience. 2023; 26(3):106074.
PMID: 36879801
PMC: 9984560.
DOI: 10.1016/j.isci.2023.106074.
Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes.
Mone P, Lombardi A, Kansakar U, Varzideh F, Jankauskas S, Pansini A
J Pharmacol Exp Ther. 2022; 384(1):116-122.
PMID: 36549862
PMC: 9827502.
DOI: 10.1124/jpet.121.001251.
MicroRNAs in Cancer and Cardiovascular Disease.
Ilieva M, Panella R, Uchida S
Cells. 2022; 11(22).
PMID: 36428980
PMC: 9688578.
DOI: 10.3390/cells11223551.
The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity.
Alonso-Villa E, Bonet F, Hernandez-Torres F, Campuzano O, Sarquella-Brugada G, Quezada-Feijoo M
Int J Mol Sci. 2022; 23(21).
PMID: 36362356
PMC: 9659086.
DOI: 10.3390/ijms232113573.
Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M, Sun Y, Shan X, Yang F, Chu G, Chen Q
Cell Mol Biol Lett. 2022; 27(1):85.
PMID: 36209049
PMC: 9548149.
DOI: 10.1186/s11658-022-00379-9.
Mitochondrial microRNAs Are Dysregulated in Patients with Fabry Disease.
Gambardella J, Fiordelisi A, Sorriento D, Cerasuolo F, Buonaiuto A, Avvisato R
J Pharmacol Exp Ther. 2022; 384(1):72-78.
PMID: 35764328
PMC: 9827504.
DOI: 10.1124/jpet.122.001250.
miRNA Regulatory Networks Associated with Peripheral Vascular Diseases.
Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Feldo M, Kocki J
J Clin Med. 2022; 11(12).
PMID: 35743538
PMC: 9224609.
DOI: 10.3390/jcm11123470.